Susquehanna International Group, LLP Xeris Biopharma Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 406,202 shares of XERS stock, worth $3.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
406,202
Previous 637,782
36.31%
Holding current value
$3.72 Million
Previous $3.5 Million
45.84%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding XERS
# of Institutions
208Shares Held
89.9MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$94.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$89.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$35.1 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$34.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$33.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.24B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...